India News | Biological E to Submit Final Data on Its COVID-19 Vaccine Corbevax Till November End: Sources
Get latest articles and stories on India at LatestLY. Biological E will submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources on Thursday.
By Shalini Bhardwaj
New Delhi [India], October 14 (ANI): Biological E will submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources on Thursday.
Also Read | Hyderabad Shocker: 47-Year-Old Man Murders Wife Over Suspicion on Character, Absconding.
Earlier, on September 2, NITI Aayog Member (Health) VK Paul had said that the Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year.
Paul had told ANI that Phase 3 of Biological E's trial is underway. "Stockpile is being produced. We should wait for the results. We hope it'll be in the next month or two. They've made a broad commitment that they'll supply a significant amount by year-end."
Also Read | Hyderabad: 26-Year-Old Woman Ends Life After Argument With Husband; Case Registered.
The Union Health Ministry had announced in June that the Biological E would supply 30 crore doses of Corbevax to India by December.
The Drug Controller General of India (DCGI) on Wednesday granted the company permission to conduct phase 2/3 clinical trials of the 'Made in India' COVID-19 vaccine for children of age group 5-18 years on certain conditions, sources told ANI.
Further, they said that the trial will be conducted across 10 sites in the county. "The permission has been given to Biological E after the recommendation from the Subject Expert Committee," they added.
It is to be noted that the government has made an advance payment of Rs 1,500 crore to Biological E for 30 crore vaccines. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)